Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Central South University Xiangya School of Medicine, Changsha, China.
CNS Neurosci Ther. 2012 Aug;18(8):647-51. doi: 10.1111/j.1755-5949.2012.00336.x. Epub 2012 May 28.
Some study found that ATP-binding cassette (ABC) efflux transporters play an important role in antiepileptic drug resistance, especially ABCB1 and ABCC2. The aims of this study were to evaluate the relationship between the genetic polymorphisms of ABCC2 and ABCB1 and the therapeutic efficacy of antiepileptic drugs (AEDs) in Chinese epileptic patients.
ABCB1 rs1045642 (3435C>T) and ABCC2 rs717620 (-24C>T), rs3740066 (3972C>T), and rs2273697 (1249G>A) polymorphisms loci in 537 Chinese epilepsy patients (217 drug resistant patients and 320 drug responders) were genotyped by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP).
ABCC2 rs717620 -24TT genotype was significantly associated with drug resistant epilepsy (odds ratio [OR]= 4.06 [1.79-9.20], P= 0.001). The OR values of ABCC2 rs717620 -24 CT+TT genotypes and ABCC2 rs3740066 (3972C>T) CT+TT genotypes were markedly higher in drug resistant patients (OR = 1.57 [1.08-2.29], P= 0.018; OR = 1.49 [1.02-2.18], P= 0.038, respectively) compared with responsive patients. ABCC2 rs2273697 (1249G>A) and ABCB1 rs1045642 (3435C>T) polymorphisms were not associated with drug resistant epilepsy. Linkage disequilibrium (LD) test showed that the ABCC2 rs717620 were in strong LD with rs2273697 (D'= 0.694) and rs3740066 (D'= 0.699). The frequencies of haplotypes TGT (ABCC2 -24C>T/ABCC2 1249G>A/ABCC2 3972C>T) in resistant patients was significantly higher than those in responsive patients (21.0% vs. 14.2%, P < 0.05).
ABCC2-24C>T, 3972C>T polymorphisms and one ABCC2 haplotype is associated with AED resistance; ABCC2 1249G>A and ABCB1 3435C>T polymorphisms are not associated with AED resistance in our study. These data suggest that ABCC2 polymorphisms and haplotype may affect the response of antiepileptic drugs.
一些研究发现三磷酸腺苷结合盒(ABC)外排转运蛋白在抗癫痫药物耐药中发挥重要作用,尤其是 ABCB1 和 ABCC2。本研究旨在评估 ABCC2 和 ABCB1 基因多态性与中国癫痫患者抗癫痫药物(AED)治疗效果的关系。
采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)方法对 537 例中国癫痫患者(217 例耐药患者和 320 例耐药患者)ABCB1 rs1045642(3435C>T)和 ABCC2 rs717620(-24C>T)、rs3740066(3972C>T)和 rs2273697(1249G>A)多态性位点进行基因分型。
ABCC2 rs717620-24TT 基因型与耐药性癫痫显著相关(比值比[OR]=4.06[1.79-9.20],P=0.001)。耐药患者 ABCC2 rs717620-24CT+TT 基因型和 ABCC2 rs3740066(3972C>T)CT+TT 基因型的 OR 值明显高于反应性患者(OR=1.57[1.08-2.29],P=0.018;OR=1.49[1.02-2.18],P=0.038)。ABCC2 rs2273697(1249G>A)和 ABCB1 rs1045642(3435C>T)多态性与耐药性癫痫无关。连锁不平衡(LD)试验表明,ABCC2 rs717620 与 rs2273697(D'=0.694)和 rs3740066(D'=0.699)高度连锁。耐药患者中 TGT(ABCC2-24C>T/ABCC2 1249G>A/ABCC2 3972C>T)的单体型频率明显高于反应性患者(21.0%比 14.2%,P<0.05)。
ABCC2-24C>T、3972C>T 多态性和一个 ABCC2 单体型与 AED 耐药相关;ABCC2 1249G>A 和 ABCB1 3435C>T 多态性与本研究中 AED 耐药无关。这些数据表明,ABCC2 多态性和单体型可能影响抗癫痫药物的反应。